This activity presents a discussion between world-renowned thought leaders who elucidate the effective implementation of new late-line CRC treatments in the clinical setting.

Research in Review

Adding aspirin to cancer treatment regimens can reduce mortality by 20% in patients with colon cancer, according to a meta-analysis published in PLOS One.

Read More

Despite being widely accepted as the standard of care for locally advanced rectal cancer, neoadjuvant chemoradiation (NACRT) is only used in about half of US patients with the disease, according to a recent study.

Read More

Subscribe to Colorectal Cancer